- Home
- CSTE vs ABOS Comparison
CSTE vs ABOS Comparison
Compare CSTE & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSTE
- ABOS
- Stock Information
- Founded
- CSTE 1987
- ABOS 1996
- Country
- CSTE Israel
- ABOS United States
- Employees
- CSTE N/A
- ABOS N/A
- Industry
- CSTE Building Materials
- ABOS Biotechnology: Pharmaceutical Preparations
- Sector
- CSTE Industrials
- ABOS Health Care
- Exchange
- CSTE Nasdaq
- ABOS Nasdaq
- Market Cap
- CSTE 152.7M
- ABOS 171.8M
- IPO Year
- CSTE 2012
- ABOS 2021
- Fundamental
- Price
- CSTE $4.08
- ABOS $2.40
- Analyst Decision
- CSTE Buy
- ABOS Strong Buy
- Analyst Count
- CSTE 2
- ABOS 4
- Target Price
- CSTE $5.50
- ABOS $9.00
- AVG Volume (30 Days)
- CSTE 47.3K
- ABOS 207.8K
- Earning Date
- CSTE 11-13-2024
- ABOS 11-12-2024
- Dividend Yield
- CSTE N/A
- ABOS N/A
- EPS Growth
- CSTE N/A
- ABOS N/A
- EPS
- CSTE N/A
- ABOS N/A
- Revenue
- CSTE $473,883,000.00
- ABOS N/A
- Revenue This Year
- CSTE N/A
- ABOS N/A
- Revenue Next Year
- CSTE N/A
- ABOS N/A
- P/E Ratio
- CSTE N/A
- ABOS N/A
- Revenue Growth
- CSTE N/A
- ABOS N/A
- 52 Week Low
- CSTE $3.50
- ABOS $2.08
- 52 Week High
- CSTE $6.81
- ABOS $5.09
- Technical
- Relative Strength Index (RSI)
- CSTE 44.12
- ABOS 38.88
- Support Level
- CSTE $3.82
- ABOS $2.85
- Resistance Level
- CSTE $4.41
- ABOS $3.36
- Average True Range (ATR)
- CSTE 0.23
- ABOS 0.25
- MACD
- CSTE -0.01
- ABOS -0.08
- Stochastic Oscillator
- CSTE 34.67
- ABOS 3.03
About CSTE Caesarstone Ltd.
Caesarstone Ltd manufactures engineered quartz surfaces. Its products include engineered quartz and porcelain slabs, which are used as kitchen countertops in renovation and remodeling, and residential construction. It also has other applications, including vanity tops, wall panels, backsplashes, floor tiles, stairs, and other interior surfaces that are used in various residential and non-residential applications. The company sells its products under the Caesarstone brand. Caesarstone's geographical segments are the United States, Canada, Latin America, Australia, Asia, Israel, and EMEA(Europe, Middle East, Africa).
About ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.